Genmab initiates share buy-back program to reduce capital Genmab A/S has announced a share buy-back program aimed at repurchasing up to 2.2 million shares, with a total value of DKK 4.0 billion. The initiative, running until July 10, 2025, is designed to reduce the company's capital and fulfill commitments under its Restricted Stock Unit program.45